The PLK1, PhosphoMet, SGK2, and SHC1 IHC staining of tumor samples from high-risk (disease progression) patients mostly showed low cytoplasmic expression, while tumor samples from low-risk (progression-free) patients mostly showed high cytoplasmic expression. This evidence concerns the gene PLK1 and neoplasm.